PCSK9 and hyperlipidemia: PCSK9 inhibitors have significant efficacy in hyperlipidemia, atherosclerosis, and other diseases, with many reports highlighting the potential therapeutic effects of PCSK9 inhibitors in treating sepsis, tumors, and some viral infections, among other diseases.